Procurement Summary
Country : South Africa
Summary : Pharmaceutical Industry Diagnostic: South Africa
Deadline : 08 Aug 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 105076875
Document Ref. No. : 0002010363
Competition : ICB
Financier : World Bank (WB)
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
IFC—asister organization of the World Bank and member of the World Bank Group is thelargest global development institution focused on the private sector inemerging markets. IFC works in more than 100 countries, using our capital, expertise, and influence to create markets and opportunities in developingcountries. In fiscal year 2019, IFC invested more than $19 billion in privatecompanies and financial institutions in developing countries, leveraging thepower of the private sector to end extreme poverty and boost shared prosperity.For more information, visit www.ifc.org. Context and Background Africa, including South Africa, bears one of the heaviest diseaseburdens globally. However, despite this, it heavily relies on imports forpharmaceuticals, vaccines, and medical devices. The COVID-19 pandemic hasfurther exposed the limitations of the pharmaceutical industry on thecontinent. The health sector in Africa faced urgent shortages of crucialequipment and products due to disruptions in the supply chain during the peakof the pandemic. These limitations on international trade have directlyaffected the importation of APIs from countries like China and India, impactingthe availability of drug products in South Africa's healthcare system.Consequently, South Africa has recognized the need to prioritize localpharmaceutical manufacturing and export, hence the proposed project. The aim of this project is to perform a detailedexamination of the pharmaceutical and medical devices production sector inSouth Africa. The objective of the study is to assess SA-s competitiveness andpotential to grow in a number of subsectors and carve out a road map to scaleinvestment in those sectors. The study seeks to investigate the extent to whichthe enabling environment in SA facilitates private sector manufacturing anddelivery of pharmaceutical products. Itwill undertake an in-depth review of the industry's strengths, weaknesses, andopportunities, with the intention of pinpointing major barriers t...
Documents
Tender Notice